Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis

Affiliations

• ¹ Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing, China.
• ² Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing, China.
• ³ Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
• ⁴ West China Hospital of Sichuan University, Chengdu, China.
• ⁵ Blood Disease Hospital, Chinese Academy of Medical Science, Tianjin, China.
• ⁶ The First Hospital of Jilin University, Changchun, China.
• ⁷ Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
• ⁸ Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
• ⁹ Nanfang Hospital of Southern Medical University, Guangzhou, China.
• ¹⁰ The First Hospital of Soochow University, Suzhou, China.
• ¹¹ Tongji Hospital, Tongji Medical College, Wuhan, China.
• ¹² BeiGene (Beijing) Co., Ltd., Beijing, China.
• ¹³ BeiGene (Shanghai) Co., Ltd., Shanghai, China.
• ¹⁴ BeiGene USA, Inc., San Mateo, CA, USA.